These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 35265633)
1. TIGIT Signaling Pathway Regulates Natural Killer Cell Function in Chronic Hepatitis B Virus Infection. Wang J; Hou H; Mao L; Wang F; Yu J; Luo Y; Lin Q; Sun Z Front Med (Lausanne); 2021; 8():816474. PubMed ID: 35265633 [TBL] [Abstract][Full Text] [Related]
2. Restoration of CD3 Yu X; Zheng Y; Huang R; Dai X; Kang G; Wang X; Yan G; Ding B; Zheng M; Xu Y; Zong L Eur J Immunol; 2024 Aug; 54(8):e2451046. PubMed ID: 38778501 [TBL] [Abstract][Full Text] [Related]
3. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection. Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430 [TBL] [Abstract][Full Text] [Related]
4. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B. Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683 [TBL] [Abstract][Full Text] [Related]
5. Involvement of TIGIT in Natural Killer Cell Exhaustion and Immune Escape in Patients and Mouse Model With Liver Echinococcus multilocularis Infection. Zhang C; Wang H; Li J; Hou X; Li L; Wang W; Shi Y; Li D; Li L; Zhao Z; Li L; Aji T; Lin R; Shao Y; Vuitton DA; Tian Z; Sun H; Wen H Hepatology; 2021 Dec; 74(6):3376-3393. PubMed ID: 34192365 [TBL] [Abstract][Full Text] [Related]
6. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation. Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078 [TBL] [Abstract][Full Text] [Related]
7. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B. Li Y; Wang JJ; Gao S; Liu Q; Bai J; Zhao XQ; Hao YH; Ding HH; Zhu F; Yang DL; Zhao XP PLoS One; 2014; 9(2):e86927. PubMed ID: 24520324 [TBL] [Abstract][Full Text] [Related]
8. T-cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis. Bi J; Zhang Q; Liang D; Xiong L; Wei H; Sun R; Tian Z Hepatology; 2014 May; 59(5):1715-25. PubMed ID: 24319005 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B e Antigen Induces NKG2A Ma Q; Dong X; Liu S; Zhong T; Sun D; Zong L; Zhao C; Lu Q; Zhang M; Gao Y; Ye Y; Cheng J; Xu Y; Zheng M Front Cell Dev Biol; 2020; 8():421. PubMed ID: 32582704 [TBL] [Abstract][Full Text] [Related]
10. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice. Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614 [TBL] [Abstract][Full Text] [Related]
11. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling. Li M; Xia P; Du Y; Liu S; Huang G; Chen J; Zhang H; Hou N; Cheng X; Zhou L; Li P; Yang X; Fan Z J Biol Chem; 2014 Jun; 289(25):17647-57. PubMed ID: 24817116 [TBL] [Abstract][Full Text] [Related]
12. IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV infection. Tang L; Li Q; Chen L; Li X; Gu S; He W; Pan Q; Wang L; Sun J; Yi X; Li Y J Med Virol; 2023 Oct; 95(10):e29142. PubMed ID: 37815034 [TBL] [Abstract][Full Text] [Related]
13. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006 [TBL] [Abstract][Full Text] [Related]
14. Veritable antiviral capacity of natural killer cells in chronic HBV infection: an argument for an earlier anti-virus treatment. Li X; Zhou L; Gu L; Gu Y; Chen L; Lian Y; Huang Y J Transl Med; 2017 Oct; 15(1):220. PubMed ID: 29089040 [TBL] [Abstract][Full Text] [Related]
15. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection. Zheng Q; Zhu YY; Chen J; Ye YB; Li JY; Liu YR; Hu ML; Zheng YC; Jiang JJ Clin Exp Immunol; 2015 Jun; 180(3):499-508. PubMed ID: 25639451 [TBL] [Abstract][Full Text] [Related]
16. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection. Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926 [TBL] [Abstract][Full Text] [Related]
17. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B. Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390 [TBL] [Abstract][Full Text] [Related]
18. TIGIT immune checkpoint blockade enhances immunity of human peripheral blood NK cells against castration-resistant prostate cancer. Wang F; Liu S; Liu F; Xu T; Ma J; Liang J; Wang J; Liu D; Yang F; Li J; Xing N Cancer Lett; 2023 Aug; 568():216300. PubMed ID: 37414394 [TBL] [Abstract][Full Text] [Related]
19. Altered CD226/TIGIT expressions were associated with NK phenotypes in primary antiphospholipid syndrome and affected by IL-4/JAK pathway. Long Y; Lu KJ; Xia CS; Feng JH; Li WY; Ma YT; Sun YY; Fan CH; Li C Clin Exp Immunol; 2024 Apr; 216(2):132-145. PubMed ID: 38386917 [TBL] [Abstract][Full Text] [Related]
20. Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155. Zhang B; Zhao W; Li H; Chen Y; Tian H; Li L; Zhang L; Gao C; Zheng J Cancer Immunol Immunother; 2016 Mar; 65(3):305-14. PubMed ID: 26842126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]